P
NBIX icon

PensionDanmark’s Neurocrine Biosciences NBIX Stock Holding History

PensionDanmark’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.54M Buy
38,791
+4,131
+12% +$613K 0.05% 295
2026
Q1 		$4.57M Buy
34,660
+16,290
+89% +$2.16M 0.04% 336
2025
Q4 		$2.61M Buy
+18,370
New +$2.66M 0.02% 418

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

PensionDanmark's NBIX Position: Q2 2026 in Review

PensionDanmark increased its Neurocrine Biosciences (NBIX) stake by 12% in Q2 2026, buying an estimated $613K and bringing the position to 38,791 shares worth $6.54M. The position accounts for 0.05% of the portfolio, ranked #295.

PensionDanmark first reported a position in NBIX in Q4 2025 and has held it in 3 quarters since. 772 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • PensionDanmark held 38,791 shares of Neurocrine Biosciences worth $6.54M as of Q2 2026.
  • PensionDanmark bought 4,131 Neurocrine Biosciences shares in Q2 2026, an estimated $613K.
  • Neurocrine Biosciences made up 0.05% of PensionDanmark's portfolio in Q2 2026, its #295 holding.
  • PensionDanmark first reported a position in Neurocrine Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 772 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on PensionDanmark's 13F filing for Q2 2026, filed 8 Jul 2026.